학술논문

A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease.
Document Type
journal article
Source
Neurology; 1999 Apr 12, Vol. 52 Issue 6, p1146-1152, 7p
Subject
Language
ISSN
00283878